title: Development of extracellular signal-regulated kinase inhibitors.
abstract: Activation of the extracellular signal-regulated kinase (ERK) signaling pathway has been implicated in mediating a diverse array of cellular functions including cell differentiation, proliferation, and inflammatory responses. In this review, we will discuss approaches to identify inhibitors of ERK proteins through targeting ATP-dependent and ATP-independent mechanisms. Given the diversity of ERK substrates and the importance of ERK signaling in normal cell functions, emphasis will be placed on the methods for identifying small molecular weight compounds that are substrate selective through ATP-independent interactions and potentially relevant to inflammatory processes. The approach for selective targeting of ERK substrates takes advantage of the basic understanding of unique ERK docking domains that are thought to interact with specific amino acid sequences on substrate proteins. Computer aided drug design (CADD) can facilitate the high throughput screening of millions of compounds with the potential for selective interactions with ERK docking domains and disruption of substrate interactions. As such, the CADD approach significantly reduces the number of compounds that will be evaluated in subsequent biological assays and greatly increases the hit rate of biologically active compounds. The potentially active compounds are evaluated for ERK protein binding using spectroscopic and structural biology methods. Compounds that show ERK interactions are then tested for their ability to inhibit substrate interactions and phosphorylation as well as ERK-dependent functions in whole organism or cell-based assays. Finally, the relevance of substrate-selective ERK inhibitors in the context of inflammatory disease will be discussed.
authors.affiliation: Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.
authors.forename: Kimberly
authors.initials: K
authors.lastname: Burkhard
authors.forename: Sarice
authors.initials: S
authors.lastname: Smith
authors.forename: Rahul
authors.initials: R
authors.lastname: Deshmukh
authors.forename: Alexander D
authors.initials: AD
authors.lastname: MacKerell
authors.forename: Paul
authors.initials: P
authors.lastname: Shapiro
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D015195:Drug Design; D048049:Extracellular Signal-Regulated MAP Kinases / Q000037:antagonists & inhibitors*; D006801:Humans; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism; D011485:Protein Binding; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D013329:Structure-Activity Relationship
chemical_list: D047428:Protein Kinase Inhibitors; D000255:Adenosine Triphosphate; D048049:Extracellular Signal-Regulated MAP Kinases; D020928:Mitogen-Activated Protein Kinases
references.citation: Nature. 2002 Jun 27;417(6892):949-54
references.pmid: 12068308
references.citation: Biophys Chem. 2001 Nov 28;93(2-3):215-30
references.pmid: 11804727
references.citation: Mol Microbiol. 1998 Jun;28(6):1335-43
references.pmid: 9680221
references.citation: EMBO Rep. 2006 Aug;7(8):782-6
references.pmid: 16880823
references.citation: Curr Top Med Chem. 2002 Sep;2(9):1011-20
references.pmid: 12171568
references.citation: Science. 1999 Nov 12;286(5443):1374-7
references.pmid: 10558995
references.citation: Curr Drug Targets Infect Disord. 2002 Sep;2(3):217-34
references.pmid: 12462126
references.citation: J Chem Inf Model. 2007 Nov-Dec;47(6):2303-15
references.pmid: 17900106
references.citation: Nat Biotechnol. 2005 Mar;23(3):329-36
references.pmid: 15711537
references.citation: Mol Cell. 2004 Apr 9;14(1):43-55
references.pmid: 15068802
references.citation: Curr Opin Chem Biol. 2001 Dec;5(6):654-9
references.pmid: 11738175
references.citation: J Pharmacol Exp Ther. 2005 Dec;315(3):971-9
references.pmid: 16002463
references.citation: J Biol Chem. 2003 Aug 8;278(32):29901-12
references.pmid: 12754209
references.citation: Cell. 1997 Sep 5;90(5):859-69
references.pmid: 9298898
references.citation: Genes Dev. 1994 Jan;8(2):147-59
references.pmid: 8299935
references.citation: J Med Chem. 2007 Mar 22;50(6):1280-7
references.pmid: 17300186
references.citation: J Comput Aided Mol Des. 2000 Mar;14(3):251-64
references.pmid: 10756480
references.citation: Proteins. 2008 Dec;73(4):795-801
references.pmid: 18767165
references.citation: Biochem J. 2003 Apr 1;371(Pt 1):199-204
references.pmid: 12534346
references.citation: J Biol Chem. 1999 Nov 26;274(48):34029-35
references.pmid: 10567369
references.citation: Mol Cell Biol. 1998 Feb;18(2):710-20
references.pmid: 9447967
references.citation: Endocr Rev. 2001 Apr;22(2):153-83
references.pmid: 11294822
references.citation: J Med Chem. 2007 Feb 8;50(3):409-24
references.pmid: 17266192
references.citation: J Biol Chem. 1999 Jul 30;274(31):21900-7
references.pmid: 10419510
references.citation: Ann Rheum Dis. 2008 Jul;67(7):909-16
references.pmid: 17827184
references.citation: Biochim Biophys Acta. 2005 Dec 30;1754(1-2):316-23
references.pmid: 16324895
references.citation: J Biol Chem. 1995 Jul 14;270(28):16483-6
references.pmid: 7622446
references.citation: Curr Opin Drug Discov Devel. 2003 Sep;6(5):760-5
references.pmid: 14579525
references.citation: Anticancer Res. 2005 May-Jun;25(3A):1483-9
references.pmid: 16033049
references.citation: Curr Opin Struct Biol. 2003 Feb;13(1):115-21
references.pmid: 12581668
references.citation: Oncologist. 2005 Sep;10(8):565-78
references.pmid: 16177281
references.citation: Biochemistry. 2004 Sep 21;43(37):11658-71
references.pmid: 15362850
references.citation: J Cell Commun Signal. 2008 Dec;2(3-4):81-92
references.pmid: 19105050
references.citation: Lancet. 2008 Sep 20;372(9643):1073-87
references.pmid: 18805336
references.citation: Semin Oncol. 2006 Aug;33(4):369-85
references.pmid: 16890793
references.citation: J Biol Chem. 1995 Jun 23;270(25):14843-6
references.pmid: 7797459
references.citation: Expert Rev Mol Med. 2002 Apr 25;4(8):1-18
references.pmid: 14987392
references.citation: Nucleic Acids Res. 2002 Jan 1;30(1):245-8
references.pmid: 11752306
references.citation: Genes Dev. 1994 Jan;8(2):160-73
references.pmid: 8299936
references.citation: Nat Cell Biol. 2000 Feb;2(2):110-6
references.pmid: 10655591
references.citation: Curr Med Chem. 2001 Nov;8(13):1589-604
references.pmid: 11562287
references.citation: Genetics. 1998 Aug;149(4):1809-22
references.pmid: 9691039
references.citation: Trends Pharmacol Sci. 2008 May;29(5):250-7
references.pmid: 18407359
references.citation: J Biol Chem. 2008 Feb 15;283(7):3854-65
references.pmid: 18083711
references.citation: Curr Top Med Chem. 2007;7(1):63-82
references.pmid: 17266596
references.citation: Bioorg Med Chem Lett. 2006 Dec 15;16(24):6281-7
references.pmid: 17000106
references.citation: Biotechnol J. 2006 Dec;1(12):1405-18
references.pmid: 17109493
references.citation: Curr Pharm Des. 2000 Jan;6(1):59-98
references.pmid: 10637372
references.citation: Chem Biol. 2000 Apr;7(4):R85-94
references.pmid: 10779412
references.citation: Nat Struct Biol. 2002 Apr;9(4):268-72
references.pmid: 11896401
references.citation: Mol Biol Cell. 2002 Jun;13(6):2031-44
references.pmid: 12058067
references.citation: Curr Top Med Chem. 2008;8(16):1452-67
references.pmid: 18991731
references.citation: J Biol Chem. 2000 Oct 13;275(41):31755-62
references.pmid: 10915787
references.citation: J Med Chem. 2002 Jul 4;45(14):2994-3008
references.pmid: 12086485
references.citation: Curr Opin Immunol. 1993 Apr;5(2):282-6
references.pmid: 8507407
references.citation: Clin Cancer Res. 2008 Jan 15;14(2):342-6
references.pmid: 18223206
references.citation: Biochem Biophys Res Commun. 2005 Oct 14;336(1):357-63
references.pmid: 16139248
references.citation: EMBO J. 2001 Feb 1;20(3):466-79
references.pmid: 11157753
references.citation: Drug News Perspect. 2008 Jun;21(5):245-50
references.pmid: 18596988
references.citation: Adv Cancer Res. 1998;74:49-139
references.pmid: 9561267
references.citation: Chembiochem. 2005 Mar;6(3):481-90
references.pmid: 15742384
references.citation: EMBO J. 2002 Sep 16;21(18):4831-40
references.pmid: 12234923
references.citation: Biochemistry. 2007 Aug 14;46(32):9187-98
references.pmid: 17658892
references.citation: Curr Opin Struct Biol. 2001 Oct;11(5):560-6
references.pmid: 11785756
references.citation: J Med Chem. 2001 Dec 6;44(25):4313-24
references.pmid: 11728179
references.citation: Trends Biochem Sci. 1996 Oct;21(10):373-4
references.pmid: 8918190
references.citation: Biochemistry. 1996 Dec 3;35(48):15143-8
references.pmid: 8952461
references.citation: J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):235-49
references.pmid: 11274893
references.citation: Science. 1992 Aug 21;257(5073):1078-82
references.pmid: 1509259
references.citation: Biochem J. 2000 Oct 1;351(Pt 1):95-105
references.pmid: 10998351
references.citation: Methods Mol Biol. 2009;503:65-88
references.pmid: 19151937
references.citation: Biochim Biophys Acta. 2004 Mar 11;1697(1-2):243-57
references.pmid: 15023365
references.citation: Biochem Biophys Res Commun. 2007 Feb 16;353(3):633-7
references.pmid: 17194451
references.citation: Rheumatology (Oxford). 2008 Apr;47(4):409-14
references.pmid: 18187523
references.citation: Pharmacol Ther. 2002 Feb-Mar;93(2-3):193-202
references.pmid: 12191611
references.citation: Drugs R D. 2008;9(6):397-434
references.pmid: 18989991
references.citation: Mol Cell. 2004 Sep 10;15(5):661-75
references.pmid: 15350212
references.citation: Eur J Cancer. 2002 Sep;38 Suppl 5:S11-8
references.pmid: 12528768
references.citation: Nature. 1994 Feb 24;367(6465):704-11
references.pmid: 8107865
references.citation: Trends Biochem Sci. 2000 Sep;25(9):448-53
references.pmid: 10973059
references.citation: Oncogene. 2007 May 14;26(22):3100-12
references.pmid: 17496909
references.citation: Curr Pharm Des. 2002;8(25):2269-78
references.pmid: 12369855
references.citation: J Biol Chem. 2000 Aug 11;275(32):24613-21
references.pmid: 10811804
references.citation: Comb Chem High Throughput Screen. 2005 Mar;8(2):181-95
references.pmid: 15777182
references.citation: EMBO J. 1998 Mar 16;17(6):1740-9
references.pmid: 9501095
references.citation: Structure. 1998 Sep 15;6(9):1117-28
references.pmid: 9753691
references.citation: Blood. 2000 Sep 1;96(5):1655-69
references.pmid: 10961860
references.citation: J Chem Inf Comput Sci. 2001 Sep-Oct;41(5):1308-15
references.pmid: 11604031
references.citation: J Med Chem. 2005 Jul 14;48(14):4586-95
references.pmid: 15999996
references.citation: Nat Cell Biol. 2002 Aug;4(8):556-64
references.pmid: 12134156
references.citation: Cancer Res. 1989 Sep 1;49(17):4682-9
references.pmid: 2547513
references.citation: J Med Chem. 2004 Jul 1;47(14):3502-11
references.pmid: 15214778
references.citation: J Mol Biol. 1982 Oct 25;161(2):269-88
references.pmid: 7154081
references.citation: J Biol Chem. 1999 Jan 29;274(5):2893-8
references.pmid: 9915826
references.citation: J Biol Chem. 2001 Jul 20;276(29):27256-65
references.pmid: 11371562
references.citation: Cancer Res. 2004 Oct 1;64(19):7099-109
references.pmid: 15466206
references.citation: Cancer Res. 2002 Dec 1;62(23):6997-7000
references.pmid: 12460918
references.citation: Methods Enzymol. 2008;439:425-49
references.pmid: 18374181
references.citation: J Biol Chem. 2001 Jan 12;276(2):965-73
references.pmid: 11029469
references.citation: Angew Chem Int Ed Engl. 2002 Aug 2;41(15):2644-76
references.pmid: 12203463
references.citation: J Chem Inf Comput Sci. 2003 Jan-Feb;43(1):267-72
references.pmid: 12546562